ALAlphabet Inc.

Institutional investor · Portfolio as of Q4 2019

Top Holdings24 positions

Checking export access…
Activity:

LYFT INCA

12.8M$551.9M33.4%$40.84+5.34%
2 qtrssince 2019-Q3
Unchanged
0
JDJD
ADR

JD.COM INC

13.6M$477.5M28.9%$24.72+24.88%
2 qtrssince 2019-Q3
Unchanged
0

DEXCOM INC

805,681$176.2M10.7%$52.30+4.55%
2 qtrssince 2019-Q3
Increased
96

UBER TECHNOLOGIES INC

3.8M$112.5M6.8%$30.47-2.40%
2 qtrssince 2019-Q3
Decreased
0

ARCUS BIOSCIENCES INC

5M$51M3.1%$9.10+10.99%
2 qtrssince 2019-Q3
Unchanged
0
3.3M$50.6M3.1%——
2 qtrssince 2019-Q3
Unchanged
0
FTSVFTSVDelisted

Forty Seven Inc

1M$40.6M2.5%——
2 qtrssince 2019-Q3
Decreased
0
WORKWORKDelisted

Slack Technologies Inc.

1.3M$29.2M1.8%——
2 qtrssince 2019-Q3
Unchanged
0

CLOUDFLARE INC

1.6M$27.9M1.7%$18.57+26.44%
2 qtrssince 2019-Q3
Unchanged
0
RAPTRAPTDelisted

RAPT THERAPEUTICS INC

836,059$23.1M1.4%——
1 qtr
New
66

VIR BIOTECHNOLOGY INC

1.7M$21M1.3%$12.580.00%
1 qtr
New
66

FULCRUM THERAPEUTICS INC

714,285$11.9M0.7%$6.64+150.60%
2 qtrssince 2019-Q3
Unchanged
0

SPERO THERAPEUTICS INC

1.1M$10.7M0.6%$10.60-9.29%
2 qtrssince 2019-Q3
Unchanged
0

QUINCE THERAPEUTICS INC

189,122$10.6M0.6%$4,986.00+125.19%
2 qtrssince 2019-Q3
Decreased
0
AUTLAUTL
ADR

AUTOLUS THERAPEUTICS LTD

699,352$9.2M0.6%$12.42+6.28%
2 qtrssince 2019-Q3
Unchanged
0

SNAP INC

523,710$8.6M0.5%$15.80+3.35%
2 qtrssince 2019-Q3
Unchanged
0

CROWDSTRIKE HLDGS INC

171,020$8.5M0.5%$14.19-12.17%
2 qtrssince 2019-Q3
Increased
48
GRTSQGRTSQDelisted

GRITSTONE BIO INC

929,022$8.3M0.5%——
2 qtrssince 2019-Q3
Unchanged
0
1.1M$6.2M0.4%——
2 qtrssince 2019-Q3
Unchanged
0

IDEAYA BIOSCIENCES INC

753,187$5.6M0.3%$9.00-16.67%
2 qtrssince 2019-Q3
Unchanged
0
$1.7B
AUM
24
Positions
Q4 2019
Filing
HI score · 2.5/5
Quarterly 13F Value Change
Not enough history yet
Activity profile
$ moved · Q4'19
New2%Increased7%Decreased91%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg <1 quarter
<1Q8%1-4Q92%1-2Y0%2Y+0%

Alphabet Inc. manages $1.7B across 24 positions as of Q4 2019. Top holdings: LYFT (33.4%), JD (28.9%), DXCM (10.7%). Fund DNA: Concentrated Value. HoldingsIntel Score: 2.5/5.0.

Q4 2019 Summary

Added RAPT and VIR; exited XYZ and SPGI; increased 2, led by DXCM (+695,224 shares); trimmed 4, led by UBER (−67.4M shares). Top move: DXCM (INCREASED, conviction 96). Portfolio: $1.7B across 24 positions.

Top holdings by portfolio weight

Total AUM$2B
LYFT33.37%
JD28.87%
DXCM10.66%
UBER6.80%
RCUS3.08%
Magenta Ther3.06%
FTSV2.45%
WORK1.77%
NET1.68%
RAPT1.40%
Other1.27%

Portfolio allocation by GICS sector

Sectors5
Technology43.73%
Consumer Cyclical29.79%
Healthcare20.38%
Unknown5.57%
Communication Services0.53%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Technology, Consumer Cyclical, Healthcare
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(2.5 / 5.0)
Holdings P&L48
Conviction36
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used